PTX3 and neoplasm: The latest research also shows that PTX3 deficiency triggers complement-dependent tumor-promoting inflammation, with enhanced tumor burden, macrophage infiltration, cytokine production, angiogenesis, and genetic instability, which increases tumor susceptibility [24].